Your browser doesn't support javascript.
loading
188Re-labeled GX1 dimer as a novel dual-functional probe targeting TGM2 for imaging and antiangiogenic therapy of gastric cancer.
Yin, Jipeng; Xin, Bo; Hui, Xiaoli; Chai, Na; Yao, Liping; Hu, Hao; Xu, Bing; Ma, Wenhui; Zhang, Mingru; Wang, Jing; Nie, Yongzhan; Zhou, Guangqing; Wang, Guanliang; Chen, Liusheng; Lu, Hongbing; Wu, Kaichun.
Afiliación
  • Yin J; School of Biomedical Engineering, Fourth Military Medical University, Xi'an 710032, China; Clinical Medical Research Center, The 75th Group Army Hospital of PLA, Dali 671003, China.
  • Xin B; Department of Oncology, No. 960 Hospital of PLA, Taian 271001, China.
  • Hui X; First Affiliated Hospital, Xi'an Jiaotong University, Xi'an 710061, China.
  • Chai N; State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, China.
  • Yao L; State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, China.
  • Hu H; State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, China.
  • Xu B; State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, China.
  • Ma W; Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
  • Zhang M; Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
  • Wang J; Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
  • Nie Y; State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, China.
  • Zhou G; Clinical Medical Research Center, The 75th Group Army Hospital of PLA, Dali 671003, China.
  • Wang G; Clinical Medical Research Center, The 75th Group Army Hospital of PLA, Dali 671003, China.
  • Chen L; Clinical Medical Research Center, The 75th Group Army Hospital of PLA, Dali 671003, China. Electronic address: benwolf008@168.com.
  • Lu H; School of Biomedical Engineering, Fourth Military Medical University, Xi'an 710032, China. Electronic address: luhb@fmmu.edu.cn.
  • Wu K; State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, China. Electronic address: kaicwu@fmmu.edu.cn.
Eur J Pharm Biopharm ; 154: 144-152, 2020 Sep.
Article en En | MEDLINE | ID: mdl-32682942
PURPOSE: The GX1 peptide (CGNSNPKSC) can specifically bind to TGM2 and possesses the ability to target the blood vessels of gastric cancer. This study intends to develop an integrated dual-functional probe with higher affinity, specificity and targeting and to characterize it in vivo and in vitro. METHODS: The dimer and tetramer of GX1 were prepared using cross-linked PEG and labeled with 99mTc. The best targeting probe [PEG-(GX1)2] was selected by gamma camera imaging in nude mouse models of gastric cancer. 188Re-PEG-(GX1)2 was prepared and characterized through cell binding analysis and competitive inhibition experiments, gamma camera imaging, MTT analysis and flow cytometry, BLI, immunohistochemistry, HE staining and biochemical analysis. RESULTS: PEG-(GX1)2 bound specifically to Co-HUVEC with higher affinity than GX1. 188Re-PEG-(GX1)2 had better ability to target gastric cancer in tumor-bearing nude mice and higher T/H ratios than 188Re-GX1. 188Re-PEG-(GX1)2 inhibited the growth of Co-HUVEC and induced apoptosis, and its effects were more robust than those of 188Re-GX1. BLI showed that 188Re-PEG-(GX1)2 inhibited tumor proliferation in vivo with a stronger effect than 188Re-GX1. Compared with 188Re-GX1, 188Re-PEG-(GX1)2 suppressed tumor angiogenesis and tumor cell proliferation and induced tumor cell apoptosis in vivo. The 188Re-PEG-(GX1)2 group did not cause visible changes in liver and kidney morphology and function in vivo. CONCLUSION: The dimer of GX1 was synthesized by using cross-linked PEG, and then 188Re-PEG-(GX1)2 was prepared. This radiopharmaceutical played both diagnostic and therapeutic functions, and gamma camera imaging could be utilized to detect the distribution of drugs in vivo during treatment. Through a series of experiments in vitro and in vivo, the feasibility of the drug was confirmed, and these results laid the foundation for the subsequent development and application of GX1.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fragmentos de Péptidos / Radioisótopos / Renio / Neoplasias Gástricas / Transglutaminasas / Proteínas de Unión al GTP / Inhibidores de la Angiogénesis / Imagen Molecular Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Eur J Pharm Biopharm Asunto de la revista: FARMACIA / FARMACOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fragmentos de Péptidos / Radioisótopos / Renio / Neoplasias Gástricas / Transglutaminasas / Proteínas de Unión al GTP / Inhibidores de la Angiogénesis / Imagen Molecular Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Eur J Pharm Biopharm Asunto de la revista: FARMACIA / FARMACOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos